| (EUR) | Mar 2026 | Y/Y change |
|---|---|---|
| Revenue | 127.43M | — |
| Operating expense | — | — |
| Net income | 38.60M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, 19KA.F returned -39.9% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -34.8% |
| 1 year | -39.9% |
| 5 years | +32.8% |
| 10 years | -9.4% |
| All-time high | €12.70 (Feb 2021) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what €1,000 in 19KA.F would be worth today ›No. CorMedix Inc. has not paid a dividend in the past 12 months.
CorMedix Inc. is part of the Healthcare sector.
CorMedix Inc. has a market cap of 538.28M EUR, based on the latest quote.
CorMedix Inc. is scheduled to report earnings on Nov 16, 2026.